- Home
- CBRE vs DXCM Comparison
CBRE vs DXCM Comparison
Compare CBRE & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBRE
- DXCM
- Stock Information
- Founded
- CBRE 1906
- DXCM 1999
- Country
- CBRE United States
- DXCM United States
- Employees
- CBRE N/A
- DXCM N/A
- Industry
- CBRE Real Estate
- DXCM Medical/Dental Instruments
- Sector
- CBRE Finance
- DXCM Health Care
- Exchange
- CBRE Nasdaq
- DXCM Nasdaq
- Market Cap
- CBRE 36.9B
- DXCM 34.1B
- IPO Year
- CBRE 2004
- DXCM 2005
- Fundamental
- Price
- CBRE $122.95
- DXCM $84.47
- Analyst Decision
- CBRE Buy
- DXCM Strong Buy
- Analyst Count
- CBRE 9
- DXCM 19
- Target Price
- CBRE $149.22
- DXCM $98.32
- AVG Volume (30 Days)
- CBRE 1.9M
- DXCM 4.0M
- Earning Date
- CBRE 07-24-2025
- DXCM 07-24-2025
- Dividend Yield
- CBRE N/A
- DXCM N/A
- EPS Growth
- CBRE 2.39
- DXCM N/A
- EPS
- CBRE 3.28
- DXCM 1.33
- Revenue
- CBRE $36,742,000,000.00
- DXCM $4,148,000,000.00
- Revenue This Year
- CBRE $14.18
- DXCM $16.66
- Revenue Next Year
- CBRE $8.44
- DXCM $15.35
- P/E Ratio
- CBRE $38.17
- DXCM $64.41
- Revenue Growth
- CBRE 13.15
- DXCM 9.11
- 52 Week Low
- CBRE $84.24
- DXCM $57.52
- 52 Week High
- CBRE $147.75
- DXCM $127.61
- Technical
- Relative Strength Index (RSI)
- CBRE 45.74
- DXCM 58.64
- Support Level
- CBRE $122.65
- DXCM $84.51
- Resistance Level
- CBRE $125.25
- DXCM $87.67
- Average True Range (ATR)
- CBRE 2.74
- DXCM 1.94
- MACD
- CBRE -0.44
- DXCM -0.51
- Stochastic Oscillator
- CBRE 29.09
- DXCM 34.37
About CBRE CBRE Group Inc
CBRE Group provides a wide range of real estate services to owners, occupants, and investors worldwide, including leasing, property and project management, and capital markets advisory. CBRE's investment management arm manages over $140 billion for clients across diverse public and private real estate strategies.
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.